Windlas Biotech Q2 Results

  • BSE: 543329
  • NSE: WINDLAS
  • ISIN: INE0H5O01029
  • Sector: Biotechnology & Drugs
BSE
831.00-1.70 (-0.20%)
Volume6.17 K
Updated: Fri 16 Jan, 2026 | 15:29:47
NSE
83226.30 (3.26%)
Volume1.26 L
Updated: Fri 16 Jan, 2026 | 15:30:03
Today: 809.00
885.00
52-Wk: 667.30
1,137.60

Q2 Results Highlights

  • Total Income
    ₹222.40 Cr.
    (18.93%)
  • Operating Profit
    ₹20.96 Cr.
    (26.66%)
  • Profit After Tax
    ₹17.80 Cr.
    (13.68%)
  • Operating Margin
    9.42%
    (6.50%)
Note: Comparison is on YoY basis

Quarterly - Windlas Biotech Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 25Jun 25QoQ CompSep 24YoY Comp
Total Operating Expense 201.44191.015.46%170.4518.18%
Depreciation/ Amortization 7.607.452.00%6.5016.86%
Operating Income 20.9619.089.87%16.5526.66%
Net Income 17.8017.660.77%15.6613.68%
Other Operating Expenses Total 20.4521.61-5.37%16.5623.48%
Net Income Before Taxes 23.5923.261.42%20.2916.28%
Total Revenue 222.40210.095.86%187.0018.93%
Selling/ General/ Admin Expenses Total 36.4532.2313.07%30.9717.69%
Diluted Normalized EPS 8.408.340.72%7.4313.06%
Recommended For You

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market